Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) currently has a daily average trading volume of 1.67M but it saw 58711391 shares traded in last market. With a market cap of 3.76M USD, the company’s current market price of $3.95 came rising about 69.53 while comparing to the previous closing price of $2.33. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.37 and as low as $1.75. In the recent trading on the day, stock has struck highest price mark of $3.52 while lowest mark touched by it was $4.2.
Taking a look at 20-day trading activity of Sonoma Pharmaceuticals Inc (SNOA) gives us an average price of $2.38, while its current price level is -57.86% below from 52-week high level whereas it is 125.71% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.60 while that of 200 days or SMA-200 reads an average of $3.42. A closer look into the stock’s movement over the week reveals that its volatility is standing at 14.05% during that period while stretching the period over a month that decreases to 13.32%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 70.95 which implies that the stock is in overbought territory.
Over the week, SNOA’s stock price is moving 51.92% up while it is 22.29% when we observe its performance for the past one month. Year-to-date it is 46.84% up and over the past year, the stock is showing an upside performance of 31.67%.
The company is expected to be releasing its next quarterly report on 2025-Feb-04, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0. In next quarter, company is expected to be making quarterly sales of $4.34M as analysts are expecting the sales for current fiscal year at $15.47M and seeing the company making $19.41M in sales next year. Moreover, analysts are in estimates of $4.44M for current-quarter revenue.
Currently, Sonoma Pharmaceuticals Inc’s total number of outstanding shares is 1.62M with 1.25% of that held by the insiders while 1.26% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -76.51% and return on equity (ROE) at -64.83%. Stock’s beta reads 1.68. Stock has a price to book (P/B) ratio of 1.31 while price to sale or P/S ratio amounts to 0.27. Its return on asset (ROA) is -26.50% on average.
